Reasons for SARS-CoV-2 infection in children and their role in the transmission of infection according to age: a case-control study.


Journal

Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759

Informations de publication

Date de publication:
27 Sep 2021
Historique:
received: 22 06 2021
accepted: 27 08 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 8 10 2021
Statut: epublish

Résumé

The locations where children get exposed to SARS-CoV-2 infection and their contribution in spreading the infection are still not fully understood. Aim of the article is to verify the most frequent reasons for SARS-CoV-2 infection in children and their role in the secondary transmission of the infection. A case-control study was performed in all SARS-CoV-2 positive children (n = 81) and an equal number of age- and sex- matched controls who were referred to the S. Camillo-Forlanini Pediatric Walk-in Center of Rome. The results of all SARS-CoV-2 nasopharyngeal swabs performed in children aged < 18 years from October 16 to December 19, 2020 were analyzed. School contacts were more frequent in controls than in cases (OR 0.49; 95% CI: 0.3-0.9), while household contacts were higher in cases (OR 5.09; 95% CI: 2.2-12.0). In both cases and controls, school contacts were significantly less frequent, while on the contrary household contacts seemed to be more frequent in nursery school children compared to primary school or middle/high school children. A multivariate logistic regression showed that the probability of being positive to SARS-CoV-2 was significantly lower in children who had school contacts or who had flu symptoms compared to children who had household contacts. Results showed a 30.6% secondary attack rate for household contacts. In our study population, the two most frequent reasons for SARS-CoV-2 infection were school and home contacts. The risk of being positive was 5 times lower in children who had school contacts than in children who had household contacts.

Sections du résumé

BACKGROUND BACKGROUND
The locations where children get exposed to SARS-CoV-2 infection and their contribution in spreading the infection are still not fully understood. Aim of the article is to verify the most frequent reasons for SARS-CoV-2 infection in children and their role in the secondary transmission of the infection.
METHODS METHODS
A case-control study was performed in all SARS-CoV-2 positive children (n = 81) and an equal number of age- and sex- matched controls who were referred to the S. Camillo-Forlanini Pediatric Walk-in Center of Rome. The results of all SARS-CoV-2 nasopharyngeal swabs performed in children aged < 18 years from October 16 to December 19, 2020 were analyzed.
RESULTS RESULTS
School contacts were more frequent in controls than in cases (OR 0.49; 95% CI: 0.3-0.9), while household contacts were higher in cases (OR 5.09; 95% CI: 2.2-12.0). In both cases and controls, school contacts were significantly less frequent, while on the contrary household contacts seemed to be more frequent in nursery school children compared to primary school or middle/high school children. A multivariate logistic regression showed that the probability of being positive to SARS-CoV-2 was significantly lower in children who had school contacts or who had flu symptoms compared to children who had household contacts. Results showed a 30.6% secondary attack rate for household contacts.
CONCLUSION CONCLUSIONS
In our study population, the two most frequent reasons for SARS-CoV-2 infection were school and home contacts. The risk of being positive was 5 times lower in children who had school contacts than in children who had household contacts.

Identifiants

pubmed: 34579754
doi: 10.1186/s13052-021-01141-1
pii: 10.1186/s13052-021-01141-1
pmc: PMC8474731
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

193

Informations de copyright

© 2021. The Author(s).

Références

MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1631-1634
pubmed: 33151916
Euro Surveill. 2020 May;25(21):
pubmed: 32489179
Acta Paediatr. 2021 Sep;110(9):2567-2573
pubmed: 34053108
World J Clin Cases. 2020 Aug 26;8(16):3465-3473
pubmed: 32913853
Arch Dis Child. 2020 Jul;105(7):618-619
pubmed: 32371442
Clin Infect Dis. 2021 Sep 15;73(6):e1261-e1269
pubmed: 33709135
MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):749-752
pubmed: 34014913
Euro Surveill. 2020 Dec;25(49):
pubmed: 33303065
Pediatr Infect Dis J. 2021 Apr 1;40(4):e146-e150
pubmed: 33464019
J Korean Med Sci. 2021 Feb 01;36(5):e45
pubmed: 33527787
Euro Surveill. 2020 Sep;25(38):
pubmed: 32975186
Z Gesundh Wiss. 2022;30(5):1155-1161
pubmed: 33078090
Front Pediatr. 2021 Jan 14;8:615894
pubmed: 33520898
Health Lit Res Pract. 2020 Aug 6;4(3):e161-e165
pubmed: 32926171
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):613-616
pubmed: 32780809
Emerg Infect Dis. 2021 Jan;27(1):
pubmed: 33256891
BMJ. 2021 Jul 23;374:n1866
pubmed: 34301635
Pediatr Rep. 2021 Jun 01;13(2):257-278
pubmed: 34205837
Ital J Pediatr. 2021 Feb 2;47(1):23
pubmed: 33531046
Emerg Infect Dis. 2020 Oct;26(10):2361-2369
pubmed: 32692648
J Med Virol. 2021 Mar;93(3):1414-1420
pubmed: 32767703
J Infect Dis. 2021 Feb 13;223(3):362-369
pubmed: 33119738
Pediatr Infect Dis J. 2020 Aug;39(8):e202-e204
pubmed: 32496407
Int J Environ Res Public Health. 2021 Jul 15;18(14):
pubmed: 34300005
JAMA Pediatr. 2021 Feb 1;175(2):143-156
pubmed: 32975552
Lancet Child Adolesc Health. 2020 Nov;4(11):807-816
pubmed: 32758454
MMWR Morb Mortal Wkly Rep. 2021 Jul 16;70(28):997-1003
pubmed: 34264908
Health Lit Res Pract. 2020 Aug 6;4(3):e171-e173
pubmed: 32926173
Ital J Pediatr. 2020 May 19;46(1):62
pubmed: 32429991
PLoS One. 2020 Nov 20;15(11):e0242765
pubmed: 33216817
Lancet Reg Health Eur. 2021 Jun;5:100092
pubmed: 34104904
Pediatrics. 2021 Apr;147(4):
pubmed: 33419869
Eur J Public Health. 2021 Oct 26;31(5):1105-1107
pubmed: 33956945
Health Lit Res Pract. 2020 Aug 6;4(3):e166-e170
pubmed: 32926172
Emerg Infect Dis. 2020 Oct;26(10):2465-2468
pubmed: 32673193
J Glob Health. 2020 Jun;10(1):011101
pubmed: 32612817
Pediatr Int. 2022 Jan;64(1):e14912
pubmed: 34233075
JAMA Netw Open. 2021 Apr 1;4(4):e2111125
pubmed: 33914054
BMJ Paediatr Open. 2021 Feb 4;5(1):e000971
pubmed: 34192193
Clin Infect Dis. 2020 Jul 28;71(15):825-832
pubmed: 32277759

Auteurs

Mauro Calvani (M)

Operative Unit of Pediatrics, San Camillo-Forlanini Hospital, 00151, Rome, Italy. maurocalvani58@gmail.com.
, Rome, Italy. maurocalvani58@gmail.com.

Giulia Cantiello (G)

Department of Maternal, Infantile and Urological Sciences, Sapienza University of Rome, 00161, Rome, Italy.

Maria Cavani (M)

Department of Maternal, Infantile and Urological Sciences, Sapienza University of Rome, 00161, Rome, Italy.

Eleonora Lacorte (E)

National Centre for Disease Prevention and Health Promotion, National Institute of Health, 00161, Rome, Italy.

Bruno Mariani (B)

Laboratory of Microbiology and Virology, San Camillo-Forlanini Hospital, 00151, Rome, Italy.

Valentina Panetta (V)

L'altrastatistica srl, Consultancy & Training, Biostatistics office, Rome, Italy.

Pasquale Parisi (P)

NESMOS Department, Faculty of Medicine & Psychology, "Sapienza" University, c/o Sant'Andrea Hospital, Rome, Italy.

Gabriella Parisi (G)

Laboratory of Microbiology and Virology, San Camillo-Forlanini Hospital, 00151, Rome, Italy.

Federica Roccabella (F)

Child Neurology, NESMOS Department, Faculty of Medicine & Psychology, "Sapienza" University, c/o Sant'Andrea Hospital, Rome, Italy.

Paola Silvestri (P)

Department of Maternal, Infantile and Urological Sciences, Sapienza University of Rome, 00161, Rome, Italy.

Nicola Vanacore (N)

Department of Maternal, Infantile and Urological Sciences, Sapienza University of Rome, 00161, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH